Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, announced that it expects to file its 10K-SB annual report with the Securities and Exchange Commission on Monday, November 30, for the 2009 fiscal year ended August 31, 2009. Chairman and CEO Walt Woltosz will host a conference call and webinar [...]

Continue reading " Simulations Plus Sets Date for Fiscal Year 2009 Earnings Release and Conference Call "

IASIS Healthcare LLC (“IASIS”) announced financial and operating results for the fiscal fourth quarter and year ended September 30, 2009. Net revenue for the fourth quarter totaled $620.1 million, an increase of 20.3%, compared to $515.4 million in the prior year quarter. Adjusted EBITDA for the fourth quarter totaled $67.9 million, an increase of 17.2%, [...]

Continue reading " IASIS Healthcare Announces Fourth Quarter and Year-End 2009 Results "

ArthroCare Corp. (Pink Sheets: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced the release of its financial results for the third quarter of 2009 and filed its Form 10-Q for the period ended September 30, 2009 with the Securities and Exchange Commission (SEC). With the filing of this document, the Company is [...]

Continue reading " ArthroCare Announces Financial Results for the Third Quarter of 2009 "

AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) reported unaudited financial results for the three and twelve months ended September 30, 2009. For the fourth quarter of fiscal 2009, AVANIR reported a net loss from continuing operations of $7.0 million, or $0.09 per share, compared with a net loss from continuing operations of $5.2 million, or $0.07 per share, [...]

Continue reading " AVANIR Pharmaceuticals Announces Fiscal 2009 Fourth Quarter and Full Year Financial Results "

BioTime, Inc. (NYSE Amex:BTIM) reported financial results for the quarter ended September 30, 2009 and an update. For the three months ended September 30, 2009, BioTime’s total quarterly revenue (including royalty income, revenue recognition of deferred license fees, and grant income) increased 5% to $446,993 from $426,931 for the same period last year. Related posts [...]

Continue reading " BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent Developments "

Dynacq Healthcare, Inc. (DYII) reported a loss from continuing operations for the year ended August 31, 2009 of $0.03 per share compared to income from continuing operations of $0.32 per share in the previous year. The share amounts are calculated on a fully diluted basis. Related posts Medical Health Insurance in Florida: Allegiance Financial Notes [...]

Continue reading " Dynacq Healthcare, Inc. Announces Financial Results for the Year Ended August 31, 2009 "

Retractable Technologies, Inc. (the “Company”) (AMEX: RVP), a leading maker of safety needle medical devices, reported revenues of $10.8 million for the three months ended September 30, 2009, an increase of 19.5% over the same period in 2008. The increase in total revenues from the year-ago quarter was partially due to the sales generated as [...]

Continue reading " Retractable Technologies, Inc. Has 3Q 2009 Revenues Increase 19.5 Percent Over 3Q 2008 "

Regulatory News: RaySearch Laboratories (STO:RAYB): JANUARY 1 – SEPTEMBER, 30 2009 • Net sales for the period amounted to SEK 47.3 M (41.3) • Profit after tax was SEK 12.6 M (7.3) and earnings per share amounted to SEK 0.37 (0.21) • Operating profit was SEK 17.1 M (8.0) • Cash flow totaled SEK 5.4 [...]

Continue reading " RaySearch Laboratories AB (publ) Interim report January 1 – September 30, 2009 "

Sirona (Nasdaq: SIRO), the dental technology leader, today announced that it will release its financial results for the fourth quarter and full year ended September 30, 2009 on Friday, December 4, 2009 before the market opens and hold its conference call later that morning, commencing at 8:30 a.m. ET. Related posts Peter Rost of Pfizer [...]

Continue reading " Sirona Dental Systems, Inc. Fiscal 2009 Fourth Quarter and Full Year Earnings Release Scheduled for December 4th "

Tongjitang Chinese Medicines Company (NYSE: TCM) (“Tongjitang” or the “Company”), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, announced its financial results for the quarter ended September 30, 2009 and the repurchase of ordinary shares in a private transaction. Related posts Medical Health [...]

Continue reading " Tongjitang Chinese Medicines Company Reports Third Quarter 2009 Financial Results and Share Repurchase "